Order Article Reprints

Tiron CE, Luta G, Ghiarasim R, Tiron A, Nastasa V, Anita DC, Iversen TG, Skotland T, Sandvig K, Mares M, et al. Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer Cell Lines. Pharmaceutics. 2025; 17(12):1554. https://doi.org/10.3390/pharmaceutics17121554

Tiron, Crina Elena, Gabriel Luta, Razvan Ghiarasim, Adrian Tiron, Valentin Nastasa, Dragos Constantin Anita, Tore Geir Iversen, Tore Skotland, Kirsten Sandvig, Mihai Mares, and et al. 2025. "Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer Cell Lines" Pharmaceutics 17, no. 12: 1554. https://doi.org/10.3390/pharmaceutics17121554

Tiron, C. E., Luta, G., Ghiarasim, R., Tiron, A., Nastasa, V., Anita, D. C., Iversen, T. G., Skotland, T., Sandvig, K., Mares, M., & Dimofte, M.-G. (2025). Trastuzumab-Conjugated pH-Sensitive Micelles Exhibit Antitumor Activity and Induce Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer Cell Lines. Pharmaceutics, 17(12), 1554. https://doi.org/10.3390/pharmaceutics17121554